Skip to content

CapEx at other companies

Amgen logo
AmgenAMGN
$712M+73.2%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$109M-5.2%
AbbVie logo
AbbVieABBV
$265M+12.8%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$9.1M-15.0%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$769K+0.4%

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+25.5%
Enterprise value$1.71B+27.1%
P/S3.6×+0.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's capex?
Ardelyx (ARDX) reported capex of $69K in Q1 2026.
How has Ardelyx's capex changed year-over-year?
Ardelyx's capex decreased by 78.8% year-over-year, from $325K to $69K.
What is the long-term trend for Ardelyx's capex?
Over 4 years (2021 to 2025), Ardelyx's capex has grown at a -6.6% compound annual growth rate (CAGR), from $1.96M to $1.49M.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.